Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -273.43% is 48% above its 5-year average of -526.80%, near the high end of its 5-year range (-5983.26%–-144.87%).
14.26% below its 12-month average of -239.30%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -216.93%.
OPERATING MARGIN
-273.43%
OPERATING MARGIN AVG TTM
-239.30%
OPERATING MARGIN AVG 3Y
-336.67%
OPERATING MARGIN AVG 5Y
-526.80%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-14.26%
CURRENT VS 3Y AVG
+18.78%
CURRENT VS 5Y AVG
+48.10%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 706 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Hyperfine, Inc.
Market Cap
$76.19M
Operating Margin
-273.43%
TTM Avg
-239.30%
3Y Avg
-336.67%
5Y Avg
-526.80%
Market Cap
$76.19M
Operating Margin
-56.06%
TTM Avg
-77.78%
3Y Avg
-106.34%
5Y Avg
-131.30%
Market Cap
$74.43M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13254.09%
5Y Avg
-12240.62%
Market Cap
$77.54M
Operating Margin
-145459.36%
TTM Avg
-145459.36%
3Y Avg
-145459.36%
5Y Avg
-145459.36%
Market Cap
$79.46M
Operating Margin
-132871.32%
TTM Avg
-92244.12%
3Y Avg
-51098.97%
5Y Avg
-37173.74%
Market Cap
$80.04M
Operating Margin
-52.96%
TTM Avg
-64.09%
3Y Avg
-81.91%
5Y Avg
-87.35%
Market Cap
$81.45M
Operating Margin
-408.41%
TTM Avg
-360.51%
3Y Avg
-288.53%
5Y Avg
-284.25%
Market Cap
$82.53M
Operating Margin
-42.06%
TTM Avg
-31.00%
3Y Avg
-37.02%
5Y Avg
-45.87%
Market Cap
$70.44M
Operating Margin
-96.01%
TTM Avg
-72.88%
3Y Avg
-81.45%
5Y Avg
-72.54%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hyperfine, Inc. (HYPR) | $76.19M | -273.43% | -239.30% | -336.67% | -526.80% |
| Outset Medical, Inc. (OM)vs › | $76.19M | -56.06% | -77.78% | -106.34% | -131.30% |
| Gain Therapeutics, Inc. (GANX)vs › | $74.43M | 0.00% | 0.00% | -13254.09% | -12240.62% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | -145459.36% | -145459.36% | -145459.36% | -145459.36% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | -132871.32% | -92244.12% | -51098.97% | -37173.74% |
| Pulmonx Corporation (LUNG)vs › | $80.04M | -52.96% | -64.09% | -81.91% | -87.35% |
| Nutriband Inc. (NTRB)vs › | $81.45M | -408.41% | -360.51% | -288.53% | -284.25% |
| LENSAR Inc (LNSR)vs › | $82.53M | -42.06% | -31.00% | -37.02% | -45.87% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.44M | -96.01% | -72.88% | -81.45% | -72.54% |
| MediciNova, Inc. (MNOV)vs › | $82.73M | -3242.47% | -1621.23% | -1058.13% | -747.59% |
Gross Margin
51.4%
Operating Margin
-273.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -216.93% |
| 2026-03-31 | -219.27% |
| 2025-12-31 | -144.87% |
| 2025-09-30 | -259.53% |
| 2025-06-30 | -355.90% |
| 2025-03-31 | -510.15% |
| 2024-12-31 | -463.81% |
| 2024-09-30 | -300.93% |
| 2024-06-30 | -298.71% |
| 2024-03-31 | -323.22% |
| 2023-12-31 | -432.95% |
| 2023-09-30 | -504.68% |
| 2023-06-30 | -345.81% |
| 2023-03-31 | -494.69% |
| 2022-12-31 | -957.09% |
| 2022-09-30 | -565.67% |
| 2022-06-30 | -1512.85% |
| 2022-03-31 | -1575.28% |
| 2021-12-31 | -5983.26% |
| 2021-09-30 | -4417.79% |
| 2021-06-30 | -4074.30% |
| 2021-03-31 | -2358.01% |
| 2020-12-31 | -3314.01% |
| 2020-09-30 | -15337.84% |
| 2020-06-30 | -21912.00% |
| 2020-03-31 | -21912.00% |
